Bleeding bone surface

The term Bleeding bone surface refers to a clinical or surgical condition rather than a specific molecular target, receptor, or enzyme. In orthopedic, neurological, and dental surgeries, a bleeding bone surface occurs when the vascularized cortical or cancellous bone is cut or decorticated, leading to hemorrhage from the intraosseous vessels. While it is a site of therapeutic intervention for hemostatic agents like bone wax or topical thrombin, it does not possess the characteristics of a pharmacological target such as a defined protein structure or signaling pathway. Consequently, it is classified as a surgical site or clinical observation rather than a therapeutic molecular target. Management of this surface is critical for maintaining a clear surgical field and preventing postoperative hematoma.

Other names

Cancellous bone bleedingOsseous hemorrhage

Hemostatic agents applied to bleeding bone surfaces typically work through mechanical tamponade (e.g., bone wax) or by accelerating the coagulation cascade (e.g., topical thrombin) to achieve local hemostasis.